Please assess the completion status of the following clinical trial:

Trial Title: Dose-Finding Study of PDC31 in Patients With Primary Dysmenorrhea

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Otherwise healthy females with a history of primary dysmenorrhea~* Using effective birth control excluding intrauterine contraceptive device (IUCD)~* Must be 18 years of age or older~* Must give written informed consent to participate in this study~Exclusion Criteria:~* Patients with an intrauterine contraceptive device or using oral contraceptives within 3 months of treatment in this study~* Patients with confirmed pelvic inflammatory disease, endometriosis or adenomyosis~* Patients who are pregnant or who test positive at baseline or are at risk of becoming pregnant while on study~* Patients who are breastfeeding~* Patients with hepatic or renal function tests greater than the upper limit of normal and deemed clinically significant by the Investigator at screening~* Patients with a clinically significant medical or psychiatric disorder or a serious medical conditions within the past 6 months which in the opinion of the investigator, should prohibit participation in this study~* Patients who have been exposure to any investigational drug within 4 weeks prior to screening

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- PDC31 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).